DeSantis Robert - Aug 28, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Donna Spinola For: DeSantis, Robert
Stock symbol
ISRG
Transactions as of
Aug 28, 2024
Transactions value $
-$87,591
Form type
4
Date filed
8/29/2024, 05:49 PM
Previous filing
Aug 26, 2024
Next filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $54.6K +188 +3.41% $290.33 5.69K Aug 28, 2024 Direct F1
transaction ISRG Common Stock Sale -$90.8K -188 -3.3% $482.93 5.51K Aug 28, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $39.3K +188 +3.41% $208.90 5.69K Aug 29, 2024 Direct F1
transaction ISRG Common Stock Sale -$90.7K -188 -3.3% $482.21 5.51K Aug 29, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -188 -5.26% $0.00 3.38K Aug 29, 2024 Common Stock 188 $208.90 Direct F1, F2
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -188 -5.26% $0.00 3.38K Aug 28, 2024 Common Stock 188 $290.33 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.
F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.